dacarbazine has been researched along with Bone Marrow Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandal, P; Johannesen, TB; Tjønnfjord, GE; Vandraas, K | 1 |
| Bedikian, AY; Cain, S; Glass, MR; Homsi, J; Hwu, P; Hwu, WJ; Kim, KB; Papadopoulos, NE; Rudewicz, P; Vernillet, L | 1 |
| Gerson, SL; Liu, L; Nakatsuru, Y | 1 |
| Brown, MP; Selva-Nayagam, S; Singhal, N | 1 |
| Bleiberg, H; Clavel, M; Devriendt, J; Michel, J; Nicaise, C; Rozencweig, M; Vanderlinden, B | 1 |
| Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G | 1 |
| Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ | 1 |
| Antoine, E; Auclerc, G; Benhammouda, A; Bizzari, JP; Borel, C; Paraiso, D; Petit, T; Rixe, O; Soubrane, C; Weil, M | 1 |
| Balcerzak, SP; Benzies, T; Triozzi, PL; Tucker, F | 1 |
| Cohen, FB; Custodio, MC; Decter, JA; Lippman, AJ | 1 |
| Broxmeyer, HE; Buescher, ES; Chawla, SP; Cooper, S; Fenoglio, C; Frenck, RW; Hittelman, WN; Holian, A; Papadopoulos, NE; Vadhan-Raj, S | 1 |
| Avilés, A; Díaz-Maqueo, JC; Guzman, R; Torras, V | 1 |
| Baehner, RL; Grosfeld, JL; Hammond, D; Nesbit, ME; Nickerson, HJ; Sather, H | 1 |
2 review(s) available for dacarbazine and Bone Marrow Diseases
| Article | Year |
|---|---|
Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow; Bone Marrow Diseases; Brain Neoplasms; Cranial Irradiation; Dacarbazine; Dose-Response Relationship, Drug; Female; Fever; Glioblastoma; Humans; Middle Aged; Neutropenia; Severity of Illness Index; Temozolomide; Treatment Outcome | 2007 |
New antineoplastic drugs and their proper use.
Topics: Antineoplastic Agents; Asparaginase; Azacitidine; Bleomycin; Bone Marrow Diseases; Dacarbazine; Doxorubicin; Humans; Liver; Nausea; Neoplasms; Nitrosourea Compounds; Pancreatitis; Pulmonary Fibrosis; Vomiting | 1976 |
4 trial(s) available for dacarbazine and Bone Marrow Diseases
| Article | Year |
|---|---|
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Dacarbazine; DNA Mismatch Repair; Drug Administration Schedule; Female; Humans; Indoles; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Temozolomide | 2009 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vindesine | 1995 |
Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor.
Topics: Adult; Aged; Antigen-Presenting Cells; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Blood Preservation; Bone Marrow; Bone Marrow Diseases; Combined Modality Therapy; Cryopreservation; Cytotoxicity, Immunologic; Dacarbazine; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Interferon-gamma; Interleukin-2; Leukapheresis; Macrophages; Male; Middle Aged; Monocytes; Neoplasms; Recombinant Proteins; Tetanus Toxoid; Time Factors; Tumor Cells, Cultured | 1996 |
7 other study(ies) available for dacarbazine and Bone Marrow Diseases
| Article | Year |
|---|---|
Persistent bone marrow depression following short-term treatment with temozolomide.
Topics: Aged; Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Brain Neoplasms; Dacarbazine; Fatal Outcome; Filgrastim; Glioblastoma; Hemoglobinuria, Paroxysmal; Humans; Male; Receptors, Fc; Recombinant Fusion Proteins; Temozolomide; Thrombopoietin; Treatment Failure | 2016 |
Base excision repair as a therapeutic target in colon cancer.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Pair Mismatch; Bone Marrow Diseases; Chromosome Aberrations; Colonic Neoplasms; Dacarbazine; Deoxyguanosine; DNA Adducts; DNA Repair; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; Female; Humans; Hydroxylamines; Mice; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Sister Chromatid Exchange; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Combination of dacarbazine and mitomycin in advanced colorectal cancer.
Topics: Adult; Aged; Bone Marrow Diseases; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mitomycins; Rectal Neoplasms | 1982 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphatic Irradiation; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Patient Compliance; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cell Division; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Recombinant Proteins; Sarcoma; Time Factors | 1992 |
[Hodgkin's disease treated with chemotherapy at reduced dosage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Life Tables; Mexico; Remission Induction; Survival Rate; Vinblastine; Vincristine | 1990 |
Comparison of stage IV and IV-S neuroblastoma in the first year of life.
Topics: Actuarial Analysis; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Dacarbazine; Doxorubicin; Humans; Infant; Infant, Newborn; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Vincristine | 1985 |